BME100 f2016:Group14 W1030AM L1
|BME 100 Fall 2016|| Home |
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Wiki Editing Help
LAB 1 WRITE-UP
Health Care Issue
Diabetes, a group of metabolic diseases, begins when the pancreas is unable to produce sufficient insulin, or when it is incapable of responding to insulin produced in a proper way. This causes levels of sugar to rise over extended periods of time. There exist several types of diabetes, but Type 1 and 2 diabetes are the most common forms. Both forms impact glucose levels, and if it is not treated in the proper way, they can cause many complications, such as: extreme thirst, frequent urination, drowsiness, sudden vision changes, heavy breathing, and unconsciousness among others.
Diabetes management is a chronic health condition but it can be managed with proper care from doctors. Monitoring blood sugar levels several times per day is a must for those who are diagnosed with diabetes type 1 or 2. To control sugar levels, patients with type 1 must inject insulin several times a day and self-monitor blood sugar levels. To simplify this process of getting the right dose of insulin in the moment that is needed, we came up with a new device. A small diabetes implant that automatically regulates insulin by self-releasing bar.
MannKind Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. In 2014, they had approved a rapid-acin inhaled insulin therapy indicated to improve glycemic control in adults with diabetes. < http://www.mannkindcorp.com/ >
physicians- allows for more variety of treatments to offer to patients
Strong issued patents, the birth control bar is already manufactured,used, and FDA approved
"Treatment of Side Effects of Progestins and Progesterone Analogues Used for Birth Control." US5744463A. N.p., n.d. Web. 31 Aug. 2016.
Fundability Worksheet Scores